Results 13,241-13,260 of 26,396 for speaker:David Cullinane

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: The HSE does not know yet.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: When the HSE is looking back will there be documents that will not be there?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: The text states that the request for proposal, RFP, documentation for each primary tender consistently underspecified quality and service level expectations.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: The part that troubles me from a public accounts committee perspective is one we seem to be coming across this time and again. When we look at procurement the issue arises as to whether sufficient metrics are in place to allow the Committee of Public Accounts to evaluate whether or not what has been set out as the objective has actually been met. We have seen this not just in procurement...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: I am looking at what is in front of me in the report and I am not trying to put words into anyone's mouth. There are other issues that are not in the report that we could comment on which were maybe not covered. Mr. McCallion says that there were some issues he could not cover because he did not have the information. He says very clearly here there was and is - he went out of his way to...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: He is obviously saying that they are not comprehensive enough and that the measurable suite of service delivery metrics - in other words what he or the Comptroller and Auditor General or we in the Committee of Public Accounts can use as a benchmark - are not there. What I am saying to Mr. McCallion is that this is not good for public servants. That is why there is a call for people to be...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: I want to deal with management issues as well but to finish on procurement because this has come up in other areas. There seems to be a pattern where Dr. Scally says that: "There has been over-reliance on contract extensions." We have had that before and one of the reasons we were given is that not enough time was given over to looking at putting out new tenders and it might have been...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: Is that a failure on the part of the HSE?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: Okay, when I say "okay" I am saying however that there are a great many problems in that area of procurement that need to be addressed. I am still concerned that they are not being properly addressed but we will hopefully come back to look at this in the future. This is one of the areas we should follow up on. Dr. Scally also talked about the management issues and possible structural...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: Page 34.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: Identifying and the ability to identify risks is very important. He is basically saying here that there were governance issues and key weaknesses that he has identified. We are looking back and are seeing these. We want them corrected so that they do not happen again. To be corrected they have to be accepted and acknowledged. Are they accepted and acknowledged? Can Mr. McCallion see on...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: Here is what Dr. Scally said and this is my final question. I then want to make an observation. Dr. Scally goes on to say "the risk of women being harmed by systemic failures does not appear, from the information that the Scoping Inquiry has seen, to have been given due consideration". That statement will trouble many of the women affected and I saw much of their commentary. This...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: Mr. McCallion can comment on my next point at the end. Dr. Scally looked at CervicalCheck and found issues with procurement and auditing. There was the obvious issue of non-disclosure. There were issues in relation to risk management. There were issues in relation to whether proper performance management was in place or proper metrics to measure success were in place, etc. Risks with...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: Maybe we can get a note on this. I want to find out what specific actions have been taken and what practical measures have been put in place by the HSE since the Scally report in relation to the three screening services, specifically CervicalCheck, which is under the spotlight, but also the other two. What practical steps have been and will be taken across all those areas?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: Those are Dr. Scally's recommendations.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: What I am looking for from Mr. McCallion is what the HSE has done. Recommendations from Dr. Scally are no good if they are not implemented. It would be useful if the committee could get a note on what changes have been made.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: Hopefully, there will be learnings. I would make the final observation that often we put public servants, especially in middle management, in a difficult position if processes are not in place to protect people - the service users as much as those who oversee the service. Senior management have to take responsibility for that. Someone recently described the process as a train crash. I...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: I thank Mr. McCallion.

Ceisteanna ó Cheannairí - Leaders' Questions (7 Nov 2018)

David Cullinane: Yesterday the Taoiseach let the mask slip again in his latest attack on nurses and doctors in what was a vindictive attempt to shift the blame for hospital overcrowding away from him and his track record as Minister for Health, the performance of the Minister for Health and the Government. He attempted to put the blame on the shoulders of front-line staff in hospitals - nurses and doctors....

Ceisteanna ó Cheannairí - Leaders' Questions (7 Nov 2018)

David Cullinane: The Minister's response does not address the questions I put. What the Taoiseach said yesterday was very clear. It was not what the Minister has repeated today. The Taoiseach did put the blame on front-line workers. I sat here yesterday and listened to what he said and it was 1 million miles away from the response the Minister has given today. He was not talking about managers in the...